176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
16.78%
Revenue growth exceeding 1.5x Technology median of 2.55%. Joel Greenblatt would verify if operating margins keep pace with this top-line surge.
15.87%
Gross profit growth exceeding 1.5x Technology median of 2.81%. Joel Greenblatt would check if cost advantages or brand equity drive this surge.
17.31%
EBIT growth exceeding 1.5x Technology median of 9.24%. Joel Greenblatt would examine whether a unique competitive edge supports this outperformance.
17.31%
Operating income growth exceeding 1.5x Technology median of 6.89%. Joel Greenblatt would see if unique processes drive exceptional profitability.
16.33%
Net income growth 1.25-1.5x Technology median of 13.51%. Mohnish Pabrai would confirm consistent strategy or niche leadership behind these results.
16.18%
EPS growth 1.25-1.5x Technology median of 14.06%. Mohnish Pabrai would see if the company’s capital allocation strategy boosts these results.
16.42%
Diluted EPS growth near Technology median of 15.30%. Charlie Munger would expect typical industry-level share usage and profit trends.
-0.18%
Share reduction while Technology median is 0.04%. Seth Klarman would see a relative advantage if others are diluting.
-0.30%
Diluted share reduction while Technology median is 0.00%. Seth Klarman would see an advantage if others are still diluting.
-0.22%
Dividend cuts while Technology median is 0.00%. Seth Klarman would see if others maintain or grow payouts, highlighting a relative weakness.
21.67%
OCF growth 50-75% of Technology median of 37.45%. Guy Spier would see subpar cash conversion vs. peers.
24.45%
FCF growth 50-75% of Technology median of 39.54%. Guy Spier would worry about suboptimal capital allocation or weaker margins.
2457.03%
10Y revenue/share CAGR exceeding 1.5x Technology median of 78.18%. Joel Greenblatt would verify if a unique moat or brand fosters outperformance over a decade.
1057.66%
5Y revenue/share growth exceeding 1.5x Technology median of 41.66%. Joel Greenblatt would see if the company’s moat drives rapid mid-term expansion.
403.10%
3Y revenue/share growth exceeding 1.5x Technology median of 19.36%. Joel Greenblatt might see a short-term competitive advantage at play.
7201.40%
OCF/share CAGR exceeding 1.5x Technology median of 78.17% over 10 years. Joel Greenblatt would verify if a unique competitive moat underlies these cash flows.
968.99%
5Y OCF/share growth exceeding 1.5x Technology median of 56.01%. Joel Greenblatt might see a strong moat or efficient cost structure driving outperformance.
1082.05%
3Y OCF/share growth > 1.5x Technology median of 47.06%. Joel Greenblatt might see a recent competitive advantage translating into cash improvements.
9870.55%
Net income/share CAGR exceeding 1.5x Technology median of 100.00% over a decade. Joel Greenblatt might see a standout compounder of earnings.
2036.19%
5Y net income/share CAGR > 1.5x Technology median of 82.14%. Joel Greenblatt might see superior mid-term capital allocation or product strength.
698.24%
3Y net income/share CAGR > 1.5x Technology median of 41.60%. Joel Greenblatt might see a recent surge from market share gains or cost synergy.
1299.84%
Equity/share CAGR exceeding 1.5x Technology median of 21.70% over 10 years. Joel Greenblatt would see if a high ROE underlies this compounding advantage.
484.46%
5Y equity/share CAGR > 1.5x Technology median of 18.87%. Joel Greenblatt sees a possible ROE advantage or fewer share issuances boosting book value.
182.07%
3Y equity/share CAGR > 1.5x Technology median of 9.22%. Joel Greenblatt sees strong short-term returns on equity fueling net worth growth.
374.95%
Dividend/share CAGR of 374.95% while Technology is zero. Walter Schloss sees a minor improvement that could compound if the firm maintains consistent raises.
151.21%
5Y dividend/share CAGR of 151.21% while Technology is zero. Walter Schloss sees at least some improvement that could compound over time.
149.56%
3Y dividend/share CAGR of 149.56% while Technology is zero. Walter Schloss sees a slight advantage if the firm is at least inching up payouts.
25.20%
AR growth of 25.20% while Technology median is zero. Walter Schloss checks if the difference points to new credit strategy or stronger sales push.
14.67%
Inventory growth of 14.67% while Technology median is zero. Walter Schloss checks if we’re preparing for a sales push or risking overstock.
12.66%
Asset growth exceeding 1.5x Technology median of 0.81%. Joel Greenblatt confirms strong expansions matched by adequate returns on those assets.
13.52%
BV/share growth exceeding 1.5x Technology median. Joel Greenblatt checks if consistent ROE or undervalued buybacks fuel this advantage.
2.10%
Slightly rising debt while Technology median is deleveraging. Peter Lynch wonders if the firm lags behind peers in risk control or invests in more expansions.
9.71%
R&D growth of 9.71% while Technology median is zero. Walter Schloss wonders if a slight increase yields a meaningful competitive edge.
6.53%
SG&A growth far above Technology median. Jim Chanos sees potential red flags in cost management or diminishing returns on spending.